231211_Margin_Parameters_Cash_Market.xlsx
Risk Management Parameters (effective as of 11/12/23)
Announcement 9845/2023 (no English translation available)
This Announcement is available only in Greek.
Appointment of Market Maker
See the attached announcement.
AnnouncementEUROBANK EQUITIES Investment Firm S.A. - Announcement of acquisition of market making on "ORILINA PROPERTIES ANONYMI ETAIRIA EPENDYSEON SE AKINITI PERIOUSIA" stocks
Sorry, this announcement is available in Greek language only.
Purchase of own shares (08/12/2023)
Quest Holdings S.A. informs the investors that, according to article 49 of the Law 4548/2018 and in compliance with the terms of the Regulation no.2273/2003 of the Commission of the European Communities, as well as by virtue of the Decision of the Regular General Assembly of its Shareholders dated 15/06/2022 and the Decision of the Board of Directors dated 03/01/2023, proceeded on December 8, 2023 through the member of the A.S.E. “Eurobank Equities”, with the purchase of 3.000 Quest Holdings S.A.
EUROBANK EQUITIES Investment Firm S.A. - Announcement of acquisition of market making on "OPTIMA BANK S.A." stocks
Sorry, this announcement is available in Greek language only.
PRESS RELEASE
Lavipharm enters into a new asset purchase agreement
expanding its product portfolio with a new drug acquisition from Sanofi
Paiania, 11 December 2023 – Lavipharm S.A. announced today, in accordance with Regulation 596/2014/EU, that it has entered into an Asset Purhase Agreement with Sanofi for the acquisition of the pharmaceutical product Flagyl® for the Greek market.